Search

Author/Creator Parmentier, Stefani

1. Addition of sorafenib versus placebo to standard therapy in patients aged 60 years or younger with newly diagnosed acute myeloid leukaemia (SORAML): a multicentre, phase 2, randomised controlled trial. Issue 16 (December 2015)

Authors:
Röllig, Christoph; Serve, Hubert; Hüttmann, Andreas; Noppeney, Richard; Müller-Tidow, Carsten; Krug, Utz; Baldus, Claudia D; Brandts, Christian H; Kunzmann, Volker; Einsele, Hermann; Krämer, Alwin; Schäfer-Eckart, Kerstin; Neubauer, Andreas; Burchert, Andreas; Giagounidis, Aristoteles; Krause, St...
Journal:
Lancet oncology
Issue:
Volume 16:Issue 16(2015)
Page Start:
1691
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Allele‐specific PCR is a powerful tool for the detection of the MYD88 L265P mutation in diffuse large B cell lymphoma and decalcified bone marrow samples. (30th March 2015)

Authors:
Staiger, Annette M.; Ott, M. Michaela; Parmentier, Stefani; Rosenwald, Andreas; Ott, German; Horn, Heike; Griese, Ernst‐Ulrich
Journal:
British journal of haematology
Issue:
Volume 171:Number 1(2015:Oct.)
Page Start:
145
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Decitabine treatment in 311 patients with acute myeloid leukemia: outcome and impact of TP53 mutations – a registry based analysis. Issue 6 (12th May 2021)

Authors:
Middeke, Jan M.; Teipel, Raphael; Röllig, Christoph; Stasik, Sebastian; Zebisch, Armin; Sill, Heinz; Kramer, Michael; Scholl, Sebastian; Hochhaus, Andreas; Jost, Edgar; Brümmendorf, Tim H.; Naumann, Ralph; Steffen, Björn; Serve, Hubert; Altmann, Heidi; Kunzmann, Volker; Einsele, Hermann; Parmenti...
Journal:
Leukemia & lymphoma
Issue:
Volume 62:Issue 6(2021)
Page Start:
1432
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Low-dose melphalan in elderly patients with relapsed or refractory acute myeloid leukemia: A well-tolerated and effective treatment after hypomethylating-agent failure. (October 2019)

Authors:
Stratmann, Jan; van Kann, Elisabeth; Rummelt, Christoph; Koschade, Sebastian; Röllig, Christoph; Lübbert, Michael; Schaich, Markus; Parmentier, Stefani; Sebastian, Martin; Chromik, Joerg; Becker von Rose, Aaron; Ballo, Olivier; Steffen, Björn; Serve, Hubert; Brandts, Christian; Shaid, Shabnam
Journal:
Leukemia research
Issue:
Volume 85(2019)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Mesenchymal Stromal Cells for Treatment of Acute Steroid-Refractory Graft Versus Host Disease: Clinical Responses and Long-Term Outcome. (13th October 2015)

Authors:
von Dalowski, Felix; Kramer, Michael; Wermke, Martin; Wehner, Rebekka; Röllig, Christoph; Alakel, Nael; Stölzel, Friedrich; Parmentier, Stefani; Sockel, Katja; Krech, Mathias; Schmitz, Marc; Platzbecker, Uwe; Schetelig, Johannes; Bornhäuser, Martin; von Bonin, Malte
Journal:
Stem cells
Issue:
Volume 34:Number 2(2016:Feb.)
Page Start:
357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Mesenchymal Stromal Cells for Treatment of Acute Steroid‐Refractory Graft Versus Host Disease: Clinical Responses and Long‐Term Outcome. (13th October 2015)

Authors:
von Dalowski, Felix; Kramer, Michael; Wermke, Martin; Wehner, Rebekka; Röllig, Christoph; Alakel, Nael; Stölzel, Friedrich; Parmentier, Stefani; Sockel, Katja; Krech, Mathias; Schmitz, Marc; Platzbecker, Uwe; Schetelig, Johannes; Bornhäuser, Martin; von Bonin, Malte
Journal:
Stem cells
Issue:
Volume 34:Number 2(2016:Feb.)
Page Start:
357
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗